SBFM: Sunshine Biopharma Inc. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 0 sales totaling - in the last 180 days.

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-10-14New 13G stakeBJI Financial Group6.00%SEC
2026-10-13New 13G stakeCVI Investments, Inc.9.90%SEC
2026-10-05Fell below 5%Alta Partners LLC4.90%SEC

Get new insider and activist filings the morning after: daily alerts. Not investment advice.